End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-16 EDT
|
5-day change
|
1st Jan Change
|
13
CNY
|
0.00%
|
|
+4.50%
|
+143.90%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,162
|
4,078
|
3,312
|
3,404
|
2,836
|
2,962
|
Enterprise Value (EV)
1 |
4,262
|
3,079
|
2,518
|
2,886
|
2,313
|
2,451
|
P/E ratio
|
7.99
x
|
12.6
x
|
72.8
x
|
250
x
|
46.7
x
|
207
x
|
Yield
|
3.18%
|
8.09%
|
1.66%
|
1.62%
|
1.17%
|
0.3%
|
Capitalization / Revenue
|
3.64
x
|
4.41
x
|
5.88
x
|
5.42
x
|
3.82
x
|
4.5
x
|
EV / Revenue
|
3.01
x
|
3.33
x
|
4.47
x
|
4.59
x
|
3.12
x
|
3.72
x
|
EV / EBITDA
|
5.29
x
|
7.83
x
|
26.5
x
|
48.7
x
|
22.1
x
|
41.4
x
|
EV / FCF
|
12.4
x
|
24.6
x
|
25.7
x
|
-13.7
x
|
209
x
|
-679
x
|
FCF Yield
|
8.03%
|
4.06%
|
3.9%
|
-7.31%
|
0.48%
|
-0.15%
|
Price to Book
|
3.28
x
|
2.33
x
|
2.24
x
|
2.36
x
|
1.94
x
|
2.02
x
|
Nbr of stocks (in thousands)
|
547,445
|
549,598
|
551,153
|
551,731
|
551,731
|
555,769
|
Reference price
2 |
9.430
|
7.420
|
6.010
|
6.170
|
5.140
|
5.330
|
Announcement Date
|
19-03-14
|
20-04-02
|
21-04-14
|
22-04-22
|
23-04-14
|
24-04-24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,418
|
925.2
|
563.7
|
628.1
|
742.5
|
658.2
|
EBITDA
1 |
806.1
|
393.2
|
95.07
|
59.23
|
104.6
|
59.14
|
EBIT
1 |
754
|
339.7
|
32.32
|
-8.135
|
39
|
-5.253
|
Operating Margin
|
53.17%
|
36.72%
|
5.73%
|
-1.3%
|
5.25%
|
-0.8%
|
Earnings before Tax (EBT)
1 |
765.5
|
378.3
|
50.18
|
12.01
|
64.22
|
13.43
|
Net income
1 |
656
|
325.6
|
45.41
|
13.64
|
61.27
|
14.73
|
Net margin
|
46.25%
|
35.19%
|
8.06%
|
2.17%
|
8.25%
|
2.24%
|
EPS
2 |
1.180
|
0.5867
|
0.0825
|
0.0247
|
0.1100
|
0.0257
|
Free Cash Flow
1 |
342.4
|
124.9
|
98.11
|
-211.1
|
11.09
|
-3.609
|
FCF margin
|
24.14%
|
13.51%
|
17.4%
|
-33.61%
|
1.49%
|
-0.55%
|
FCF Conversion (EBITDA)
|
42.48%
|
31.78%
|
103.2%
|
-
|
10.6%
|
-
|
FCF Conversion (Net income)
|
52.2%
|
38.38%
|
216.07%
|
-
|
18.1%
|
-
|
Dividend per Share
2 |
0.3000
|
0.6000
|
0.1000
|
0.1000
|
0.0600
|
0.0160
|
Announcement Date
|
19-03-14
|
20-04-02
|
21-04-14
|
22-04-22
|
23-04-14
|
24-04-24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
900
|
999
|
795
|
518
|
523
|
511
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
342
|
125
|
98.1
|
-211
|
11.1
|
-3.61
|
ROE (net income / shareholders' equity)
|
51.3%
|
19.5%
|
2.79%
|
0.93%
|
4.22%
|
1.01%
|
ROA (Net income/ Total Assets)
|
33.5%
|
11.8%
|
1.17%
|
-0.32%
|
1.5%
|
-0.2%
|
Assets
1 |
1,959
|
2,752
|
3,885
|
-4,278
|
4,095
|
-7,490
|
Book Value Per Share
2 |
2.880
|
3.190
|
2.690
|
2.610
|
2.650
|
2.640
|
Cash Flow per Share
2 |
1.200
|
1.820
|
1.500
|
0.9300
|
0.9100
|
0.9400
|
Capex
1 |
74.8
|
92
|
104
|
251
|
107
|
85.5
|
Capex / Sales
|
5.27%
|
9.94%
|
18.51%
|
39.99%
|
14.45%
|
12.99%
|
Announcement Date
|
19-03-14
|
20-04-02
|
21-04-14
|
22-04-22
|
23-04-14
|
24-04-24
|
|
1st Jan change
|
Capi.
|
---|
| +143.90% | 1B | | +17.80% | 66.73B | | +2.92% | 49.79B | | +19.98% | 42.5B | | +20.88% | 26.45B | | +12.04% | 19.66B | | +1.27% | 17.18B | | -22.98% | 15.82B | | +2.77% | 15.56B | | -9.25% | 15.41B |
Other Specialty Chemicals
|